相关实验视频

Updated: May 24, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

变革性的CRISPR-Cas9技术:对分子机制,精确编辑技术和状细胞疾病临床进展的审查

Komal¹, Prabhjot Kaur², Nidhi Arora³

¹Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Baddowal, 141012, Ludhiana, Punjab, India.

Current drug metabolism

|March 6, 2025

概括

CRISPR-Cas9基因编辑通过纠正潜在的HBB基因突变,为治疗状细胞疾病 (SCD) 提供了一种革命性的方法. 这种先进的技术为患有这种遗传性血液疾病的患者提供了新的希望.

科学领域:

生物技术是生物技术.
遗传学是一个遗传学.
血液学血液学血液学

背景情况:

状细胞病 (SCD) 是一种遗传性血液疾病,其特点是产生异常的血红蛋白,导致红细胞变形.
SCD不成比例地影响非洲,地中海,中东和南亚血统的人口,影响全球数百万人.
对于SCD的传统治疗方法可以控制症状,但不能解决根源的遗传原因.

研究的目的:

审查CRISPR-Cas9基因编辑技术的分子机制.
探索基于CRISPR-Cas9的策略,用于修改状细胞疾病中的HBB基因.
讨论目前的临床试验和SCDCRISPR技术的进展.

主要方法:

使用CRISPR-Cas9系统,一种适用于精确基因组编辑的细菌防御机制.
使用单导向RNA将Cas9核酶引导到特定的DNA序列进行修改.
专注于先进的CRISPR变体 (例如,BE,PE) 进行大规模的DNA操纵和精确的基因校正.

主要成果:

克里斯普尔-Cas9技术能够针对性地纠正导致SCD的HBB基因突变.
先进的CRISPR变体提高了精度和速度,这对于有效的治疗应用至关重要.
基因编辑具有治疗治疗的潜力,解决SCD的遗传基础.

结论:

CRISPR-Cas9基因编辑代表了状细胞疾病的突破性治疗发展.
这项技术为解决源头上的遗传疾病提供了一个有希望的途径.
克里斯普技术的持续进步旨在提高其对SCD患者的有效性和适用性.

关键词:

在这里,我们将会看到 BE BE BE.这种技术是CRISPR-Cas9技术.这是DNA.DNA.这就是PE PE PE.状细胞疾病是一种状细胞疾病.贝塔环球蛋白是一种β环球蛋白.临床试验是指临床试验中的临床试验.这些都是专利,专利.

更多相关视频

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

What is Genetic Engineering?

What is Genetic Engineering?